Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ECG | TXNM |
|---|---|---|
| Price | $126.17 | $58.51 |
| Change today | ▲ 2.29% | ▲ 0.17% |
| Market cap | $6.44B | $6.44B |
| Return, 3 months | -5.4% | +4.2% |
| Return, year to date | +47.5% | +1.6% |
| Return, 1 year | +54.2% | +5.9% |
| P/E (TTM) | 25.3 | 32.0 |
| P/B | 8.3 | 1.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.84% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 61 | 57 |
| 30-day volatility | 39.1% | 5.5% |
| Max drawdown, 1 year | -35.5% | -5.2% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
